ATE266203T1 - Methode zur identifizierung von tumorantigenen mit autoantikörpern in serum - Google Patents

Methode zur identifizierung von tumorantigenen mit autoantikörpern in serum

Info

Publication number
ATE266203T1
ATE266203T1 AT98932884T AT98932884T ATE266203T1 AT E266203 T1 ATE266203 T1 AT E266203T1 AT 98932884 T AT98932884 T AT 98932884T AT 98932884 T AT98932884 T AT 98932884T AT E266203 T1 ATE266203 T1 AT E266203T1
Authority
AT
Austria
Prior art keywords
protein antigens
sera
patients
identification
identified
Prior art date
Application number
AT98932884T
Other languages
English (en)
Inventor
Samir M Hanash
David Misek
Robert Hinderer
Latha Prasanan
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21967731&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE266203(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Michigan filed Critical Univ Michigan
Application granted granted Critical
Publication of ATE266203T1 publication Critical patent/ATE266203T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98932884T 1997-06-26 1998-06-26 Methode zur identifizierung von tumorantigenen mit autoantikörpern in serum ATE266203T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5083297P 1997-06-26 1997-06-26
PCT/US1998/013295 WO1999000671A2 (en) 1997-06-26 1998-06-26 Method for identification of tumor antigens with autoantibodies in serum

Publications (1)

Publication Number Publication Date
ATE266203T1 true ATE266203T1 (de) 2004-05-15

Family

ID=21967731

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98932884T ATE266203T1 (de) 1997-06-26 1998-06-26 Methode zur identifizierung von tumorantigenen mit autoantikörpern in serum

Country Status (9)

Country Link
EP (1) EP0991945B2 (de)
JP (2) JP4065574B2 (de)
AT (1) ATE266203T1 (de)
AU (1) AU8267398A (de)
CA (2) CA2665707C (de)
DE (1) DE69823660D1 (de)
DK (1) DK0991945T4 (de)
ES (1) ES2216295T5 (de)
WO (1) WO1999000671A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1295668A (zh) * 1998-02-13 2001-05-16 牛津糖科学(英国)有限公司 用于肝细胞癌诊断的方法和组合物
US6645465B2 (en) 1999-08-06 2003-11-11 Michigan, University Of The Regents Annexin proteins and autoantibodies as serum markers for cancer
US6306615B1 (en) * 1999-08-19 2001-10-23 Tularik Inc. Detection method for monitoring β tubulin isotype specific modification
US7214498B2 (en) 2001-03-23 2007-05-08 Benaroya Research Institute At Virginia Mason Tumor associated antigens and methods of using the same
DE10151051B4 (de) * 2001-09-14 2007-07-12 Zeidler, Reinhard, Dr. Identifizierung von Antigenen durch xenogene, allogene oder autologe Antikörper-vermittelte Präzipitation
CA2462216A1 (en) * 2001-11-09 2003-08-07 Benaroya Research Institute At Virginia Mason Antigen panels and methods of using the same
GB2395270B (en) * 2002-11-14 2006-08-16 Univ Nottingham Tumour marker proteins and uses thereof
AU2003903317A0 (en) * 2003-06-27 2003-07-10 Proteome Systems Intellectual Property Pty Ltd Method of isolating a protein
KR20080073740A (ko) * 2005-11-10 2008-08-11 유니버시티 오브 캔터키 폐암 진단 검사
EP2041569A4 (de) * 2006-07-08 2009-11-18 Univ Kentucky Res Found Assay zur diagnose von lungenkrebs
JP2011107064A (ja) * 2009-11-20 2011-06-02 Nitto Boseki Co Ltd クラスリン重鎖に対する自己抗体の免疫測定方法、それに用いるキット、及びそれを用いた癌判定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2062675A1 (en) * 1991-04-09 1992-10-10 Sandra S. Fenton Endometrial antigen, composition, test kit and method for endometrial antibody determination
US5405749A (en) * 1991-12-06 1995-04-11 Polans; Arthur S. Method for identifying and purifying a cancer associated retinopathy autoantigen, and testing patient serum for the autoantibody to the autoantigen
WO1994028021A1 (en) * 1993-05-28 1994-12-08 Medical University Of South Carolina Endometrial proteins, antigenic compositions and methods for detecting endometriosis

Also Published As

Publication number Publication date
DK0991945T4 (da) 2008-06-09
EP0991945A2 (de) 2000-04-12
ES2216295T5 (es) 2008-06-01
WO1999000671A2 (en) 1999-01-07
WO1999000671A3 (en) 1999-06-10
DK0991945T3 (da) 2004-07-26
AU8267398A (en) 1999-01-19
CA2294514C (en) 2009-09-01
EP0991945B2 (de) 2008-02-20
CA2665707C (en) 2013-02-12
ES2216295T3 (es) 2004-10-16
CA2294514A1 (en) 1999-01-07
JP2002508835A (ja) 2002-03-19
CA2665707A1 (en) 1999-01-07
DE69823660D1 (de) 2004-06-09
JP4065574B2 (ja) 2008-03-26
EP0991945B1 (de) 2004-05-06
JP2007333744A (ja) 2007-12-27

Similar Documents

Publication Publication Date Title
CY1112631T1 (el) ΜΕΘΟΔΟΙ ΤΑΥΤΟΠΟΙΗΣΗΣ ΟΓΚΩΝ ΠΟΥ ΑΠΟΚΡΙΝΟΝΤΑΙ ΣΕ ΑΓΩΓΗ ΜΕ ΑΝΤΙΣΩΜΑΤΑ ΑΝΤΙ-ΕrbB2
DE69929185D1 (de) Tumormarker
ATE386117T1 (de) Prostattumor polynukleotid- und antigenzusammensetzungen
ATE395362T1 (de) Monoklonale antikörper zur apoptosis-induzierung
EP1565489A4 (de) Neues raag10-zelloberflächenziel und dieses ziel erkennende antikörperfamilie
CY1108450T1 (el) Μεθοδος για την ανιχνευση ν-τελικου προβνρ
EA199700447A1 (ru) Последовательность днк и кодируемый ею специфический для молочной железы белок карциномы молочной железы
CA2280930A1 (en) Protein markers for lung cancer and use thereof
DE69823660D1 (de) Methode zur identifizierung von tumorantigenen mit autoantikörpern in serum
IL142971A0 (en) S100 proteins and autoantibodies as serum markers for cancer
GR3018371T3 (en) Method for identifying or determining proteins and applications therefor.
DE3874387D1 (de) Immunologische methoden und materialien zur bestimmung von tumor assoziierten antigenen.
EP0232179A3 (en) Assay for human breast cancer
DE69126038D1 (de) Diagnose von krebs-metastasen durch das mts-1 gen
NO901461L (no) Antistoffer mot retinoblastom-genprodukt og anvendelse derav.
WO2008099419A3 (en) Autoantibodies for protein antigens as markers for cancer of gingivo-buccal complex
Kennel Characterization of a tumor cell surface protein with heterologous antisera to a spontaneous BALB/c lung carcinoma
BR0010479A (pt) Gene tipo prp
ATE323176T1 (de) Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen
ATE192236T1 (de) Menschliche phospholipase aktivierender proteinteil
CA2264963A1 (en) Protein markers for esophageal cancer
EP1572931A4 (de) Verfahren und zusammensetzungen zur modulation und zum nachweis von wisp-aktivität
Kirkeby et al. Staining of electrophoretically separated enamel proteins
WO2001066745A3 (en) Presenilin/crk binding polypeptides (pcbp) and methods of use thereof
DE69716728D1 (de) Zytofluorometrisches verfahren zur bestimmung von antikörper gegen tumorantigene im serum

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties